Funds Holding RTI Biologics, Inc.

 
Stock Quotes for RTI Biologics, Inc. top ^
  • Industry: Medical Devices
  • Sector: Healthcare
  • Stock Style: Small Core
  • Stock Type: Speculative Growth
Sign-up for rtix investment picks
  • Industry: Medical Devices
  • Sector: Healthcare
  • Stock Style: Small Core
  • Stock Type: Speculative Growth
Sign-up for rtix investment picks

 
News Articles for RTI Biologics, Inc. top ^
2013/1/31
RTI Biologics Inc. (RTI) (Nasdaq: RTIX) , a leading provider of orthopedic and other biologic implants, announced today that it plans to release financial results from the fourth quarter and year end 2012 on Thursday, Feb.
Sign-up for RTI Biologics Schedules 2012 Fourth Quarter, Year End Earnings and Conference Call for February 7, 2013 investment picks
2013/2/7
RTI Biologics Inc. (RTI) (Nasdaq:RTIX) , a leading provider of orthopedic and other biologic implants, reported operating results for the fourth quarter and full year of 2012 as follows: Quarterly Highlights: Achieved quarterly revenues of $44.6 million, a 4 percent increase over the fourth quarter of 2011.
Sign-up for RTI Biologics Announces 2012 Fourth Quarter, Full Year Results, 2013 Financial Guidance investment picks
2013/3/13
RTI Biologics Inc. (RTI) (Nasdaq:RTIX) , a leading provider of orthopedic and other biologic implants, is pleased to announce that the company has received 510(k) clearance from the U.S. Food and Drug Administration (FDA) for its porcine dermis implant.
Sign-up for RTI Biologics® Receives 510(k) Clearance for Porcine Dermis Implant investment picks
2013/3/12
RTI Biologics Inc. (RTI) (Nasdaq: RTIX) , a leading provider of orthopedic and other biologic implants, is launching a new line of biologic implants used in hernia repair procedures at the Americas Hernia Society’s 15 th Annual Hernia Repair Conference held at JW Marriott Grande Lakes, Orlando, Fla., March 13-16.
Sign-up for RTI Biologics Launches New Line of Biologic Implants at Americas Hernia Society’s 15th Annual Hernia Repair Conference, March 13-16 investment picks
2013/3/20
RTI Biologics Inc. (RTI) (Nasdaq: RTIX) , a leading provider of orthopedic and other biologic implants, is pleased to announce the results of a recent randomized prospective clinical study of BioCleanse ® -processed bone-patellar tendon-bone (BTB) allografts used in anterior cruciate ligament (ACL) reconstruction surgery.
Sign-up for RTI Biologics Announces Positive Clinical Results for BioCleanse®-Processed BTB Allografts Used in ACL Reconstruction investment picks
2013/4/18
RTI Biologics Inc. (RTI) (Nasdaq:RTIX) , a leading provider of orthopedic and other biologic implants, announced today that it plans to release financial results from the first quarter 2013 on Thursday, April 25, 2013 prior to the market open.
Sign-up for RTI Biologics Schedules 2013 First Quarter Earnings and Conference Call for April 25, 2013 investment picks
2013/4/25
RTI Biologics Inc. (RTI) (Nasdaq: RTIX) , a leading provider of orthopedic and other biologic implants, reported operating results for the first quarter of 2013 as follows: Quarterly Highlights: Achieved quarterly revenues of $40.4 million.
Sign-up for RTI Biologics Announces 2013 First Quarter Results investment picks
2013/5/23
RTI Biologics Inc. (RTI) (Nasdaq:RTIX) , a leading provider of orthopedic and other biologic implants, is pleased to announce that the company has passed the five million mark in distributing implants sterilized through its patented, validated tissue sterilization processes, BioCleanse®, Tutoplast® and Cancelle® SP, with zero incidence of implant-associated infection.
Sign-up for RTI Biologics® Announces Milestone in Tissue Processing: More than 5 Million Implants Sterilized with Zero Incidence of Implant-Associated Infection investment picks
2013/5/30
RTI Biologics Inc. (RTI) (Nasdaq: RTIX) , a leading provider of orthopedic and other biologic implants, recently donated 35 bone allograft implants to Lemoyne, Pa.-based CURE International.
Sign-up for More than 30 Kenyan Children with Severe Spinal Disorders to Benefit from RTI Biologics’ Allograft Donation to CURE International investment picks
2013/6/6
RTI Biologics Inc. (RTI) (Nasdaq:RTIX) , a leading provider of orthopedic and other biologic implants, is pleased to announce the launch of its Fortiva™ porcine dermis implant at the Abdominal Wall Reconstruction (AWR) Conference in Washington, D.C., June 6-8.
Sign-up for RTI Biologics® Launches Fortiva™ Porcine Dermis, First Human Implantation Complete investment picks

Start Premium Trial Register For Free

P F Fund Financial Data (13,000+ funds)
P F Stock Financial Data (7,000+ stocks)
P F Stock and Fund Screeners (basic)
P F Investing Articles and Market Commentary
P F Articles Archive (>30 days)
P F Discuss (dozens of stock, fund, bond, and general bulletin boards)
P F Portfolio Manager (basic)
P F Morningstar Investment Classroom
P F Morningstar Investing Classroom Rewards (earn as you learn and redeem for Morningstar merchandise)
P   Morningstar Fund Analyst Reports (full research on 2,000 funds and ETFs)
P   Morningstar Stock Analyst Reports (full research on 2,000 stocks)
P   Morningstar Stock and Fund Stewardship Grades
P   Portfolio Manager (advanced with 10 x-ray analyses, including guidance)
P   Portfolio Monitor (monthly and on-demand personalized portfolio statements)
P   Morningstar Proprietary Stock Information (stock star ratings, buy/sell prices, economic moat ratings, and more)
P   Morningstar Stock and Fund Favorites & Red Flags eNewsletters
P   Premium Stock and Fund Screeners (advanced with nearly infinite ways to find the best securities for you)
P   Discounts on Morningstar newsletters, books, seminars, and more

Sign-up to Morningstar


Basic Access

Articles and Videos
Morningstar video reports, articles, data, and tools. Dig into our lineup of e-newsletters and investing classroom courses outlining sensible strategies for maximizing your investments.
Morningstar Discuss
Follow the buzz on individual stocks or fund families. Plus, read the latest posts from Morningstar members and analysts.
Portfolio Manager
Track your investments and watch lists with our Portfolio Manager. Customize your view with our comprehensive stock, fund, and ETF data.

Access these features and more when you sign up for Free Membership.
Join Morningstar today. It's Free.

Unlimited Access

Analyst Research
Gather in-depth, actionable insight on over 3,700 stock and mutual funds covered by Morningstar analysts. View our mutual fund Analyst Reports favored by professionals, savvy experienced investors, and new investors researching options for retirement savings, college plans, or other investment needs.
Portfolio X-Ray®
Ensure your portfolio is positioned exactly how you want with Morningstar's X-Ray Interpreter and Stock Intersection tools. A Barron's "Best of the Web" award winner for five years running, X-Ray Interpreter goes under the hood of your portfolio to provide a useful allocation, sector, and geographic analysis. And you can discover how much of a stock you really own, individually and through mutual funds, with Stock Intersection.
Investment Picks
Find new 5-star stocks (greatly undervalued companies) to consider daily. Our 5-star stock rating is a proven winner, consistently beating benchmarks like the S&P 500. Plus, browse our Fund Analyst Picks and Stewardship Grades to find shareholder-friendly mutual funds that are poised for outperformance.
Portfolio Monitor
Get a clear view of your investments with personalized reports about your portfolio. Receive monthly statements and generate reports on-demand to help you stay on track to meet your investment goals.

Access these features and more when you sign up for Premium Membership.
Start your free 14-day trial today online
Your subscription may be tax deductible. Please contact your tax advisor.

Funds Holding RTI Biologics, Inc.
Name |  Ticker |  Star Rating |  Market Cap |  Stock Type |  Sector |  Industry Star Rating |  Investment Style |  Total Assets |  Category |  Top Holdings |  Top Sectors |  Symbol |  Title Star Rating |  Category |  Total Assets |  Top Holdings |  Top Sectors |  Symbol |  Name Title |  Date |  Author |  Collection |  Interest |  Popularity Name |  Ticker |  Star Rating |  Market Cap |  Stock Type |  Sector |  Industry Star Rating |  Investment Style |  Total Assets |  Category |  Top Holdings |  Top Sectors |  Symbol / Ticker |  Title Star Rating |  Category |  Total Assets |  Symbol / Ticker |  Name Title |  Date |  Author |  Collection |  Popularity |  Interest Title |  Date |  Company |  Symbol |  Interest |  Popularity Title |  Date |  Company |  Symbol |  Interest |  Popularity Topic |  Sector |  Key Indicators |  User Interest |  Market Cap |  Industry |  Topic |  Sector |  Key Indicators |  User Interest |  Market Cap |  Industry

Previous: Funds Holding RPS Group PLC  |  Next: Funds Holding Rti International Metals, Inc.